Literature DB >> 20736395

Update on the causes, investigation and management of empyema in childhood.

Woolf Walker1, Robert Wheeler, Julian Legg.   

Abstract

Despite being recognised for over two millennia and having an increasing incidence in many countries, the management of childhood empyema remains controversial. This review examines the recent literature on its causes and investigation then focuses on its treatment. Following a trial of appropriate intravenous antibiotics, the evidence would currently support the use of chest drain insertion with urokinase instillation as first line treatment with video-assisted thoracoscopic surgery to be used for failure of medical management. A treatment algorithm is proposed to guide clinical practice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20736395     DOI: 10.1136/adc.2009.165357

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  4 in total

1.  DNA bacterial load in children with bacteremic pneumococcal community-acquired pneumonia.

Authors:  S Esposito; A Marchese; A E Tozzi; G A Rossi; L Da Dalt; G Bona; C Pelucchi; G C Schito; N Principi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-25       Impact factor: 3.267

2.  Making the transition from video-assisted thoracoscopic surgery to chest tube with fibrinolytics for empyema in children: Any change in outcomes?

Authors:  Michael H Livingston; Sara Colozza; Kelly N Vogt; Neil Merritt; Andreana Bütter
Journal:  Can J Surg       Date:  2016-06       Impact factor: 2.089

Review 3.  Childhood community-acquired pneumonia: A review of etiology- and antimicrobial treatment studies.

Authors:  Gerdien A Tramper-Stranders
Journal:  Paediatr Respir Rev       Date:  2017-07-15       Impact factor: 2.726

4.  Fibrinolysis versus thoracoscopy: Comparison of results in empyema management in the child.

Authors:  Maria Rosa Ibarra Rodríguez; Jose Ignacio Garrido Pérez; Fernando Vázquez Rueda; Francisco Javier Murcia Pascual; Sandra Rocio Wiesner Torres; Rosa Maria Paredes Esteban
Journal:  Ann Thorac Med       Date:  2022-07-09       Impact factor: 2.535

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.